ZOLL Medical wins U.S. Defense defibrillator contract

NewsGuard 100/100 Score

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that it has been awarded a follow-on contract for Airworthy CCT defibrillators by the U.S. Defense Logistics Agency. If fully exercised, the potential revenue from the contract could approximate $30 million. The services that can order units against this contract are Army, Navy, Air Force, Marine Corps, and federal civilian agencies.

The Department of Defense will provide an upfront payment of $3.9 million for ZOLL to procure parts to build units to comply with inventory requirements. This payment will initially be included in deferred revenue. Recognition of revenue will occur depending upon how and when future orders are placed. ZOLL received a similar award in 2004, with four one-year extension options, all of which were exercised. This new agreement, initially for a one-year period, also contains four one-year agreement extension options.

“We are pleased, once again, to be chosen to provide equipment on a continuing basis to all military branches and federal civilian agencies with a quick turnaround to help ensure our nation’s state of readiness,” said Richard A. Packer, Chairman and CEO of ZOLL.

The date of performance completion is September 27, 2010, subject to contract extension. The Airworthy CCT is an advanced life support, critical care transport defibrillator and monitor.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DELiVR's virtual reality training speeds up cell detection in complex brain datasets